BCEL — Atreca Share News
0.000.00%
Last trade - 00:00Brief: Atreca Posts Q4 Loss Per Share Of $0.79
Atreca Inc expected to post a loss of 75 cents a share - Earnings Preview
Atreca Inc expected to post a loss of 76 cents a share - Earnings Preview
Brief: Atreca Reports Q3 2021 Financial Results And Recent Corporate Developments
Atreca jumps on agreement to develop malaria drug
Brief: Atreca - Under Agreement, Gates Mri Will Lead Development Of Mam01/Atrc-501
Atreca Inc reports results for the quarter ended in June - Earnings Summary
Brief: Atreca Posts Q2 Loss Per Share Of $0.72
Atreca Inc expected to post a loss of 69 cents a share - Earnings Preview
Atreca Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Atreca Announces Appointment Of Dr. Stacey Ma And Stephen R. Brady To Its Board Of Directors
Brief: Atreca Reports Q1 Loss Per Share Of $0.70
Atreca Inc reports results for the quarter ended in March - Earnings Summary
Brief: Atreca Reports Q4 And Full Year 2020 Financial Results
U.S. RESEARCH ROUNDUP-Affirm Holdings, Estee Lauder Companies, Hershey
Brief: Atreca reports Q3 Loss Per Share $0.66
Brief: Atreca Inc Files Prospectus On Resale Of Up To 9.5 Million Class A Stock By Selling Stockholders
Brief: Atreca Inc Entered Into A Common Stock Sales Agreement For Up To $100 Million
Brief: Atreca Posts Q2 Loss Per Share Of $0.71